Literature DB >> 17195607

[Hypertension in the elderly].

Pierre-François Plouin1, Patrick Rossignol, Guillaume Bobrie.   

Abstract

Systolic blood pressure rises with age, and the prevalence of hypertension (systolic pressure of 140 mmHg or more and diastolic pressure below 90 mmHg) exceeds 70% after the age of 70. At any age, high systolic pressure is associated with an increased risk of cardiovascular death, stroke and myocardial infarction. Antihypertensive drugs reduce cardiovascular mortality and morbidity in patients with systolic pressure exceeding 160 mmHg. The ability of blood pressure reduction to prevent cardiovascular events in elderly hypertensive patients is often compromised by poor systolic pressure control. This is due to the relatively limited efficacy of antihypertensive medications to normalize systolic blood pressure, but also to the fact that many physicians fail to follow systolic hypertension treatment guidelines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195607

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN: 0001-4079            Impact factor:   0.144


  3 in total

1.  DEspR T/CATAAAA-box promoter variant decreases DEspR transcription and is associated with increased BP in Sardinian males.

Authors:  Nicola Glorioso; Victoria L M Herrera; Tamara Didishvili; Giuseppe Argiolas; Chiara Troffa; Patrizia Bulla; Emanuela Bulla; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2011-08-23       Impact factor: 3.107

Review 2.  Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.

Authors:  Martin Wehling
Journal:  Eur J Clin Pharmacol       Date:  2014-08-28       Impact factor: 2.953

3.  Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure.

Authors:  Eros da Mota Dias; Luiz Tadeu Giollo; Débora Dada Martinelli; Camila Mazeti; Heitor Moreno Júnior; José Fernando Vilela-Martin; Juan Carlos Yugar-Toledo
Journal:  Cardiovasc Ultrasound       Date:  2012-10-18       Impact factor: 2.062

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.